Literature DB >> 23963060

A feasibility study of varenicline for smoking cessation in bipolar patients with subsyndromal depression.

Mark A Frye1, Jon O Ebbert, Courtney A Prince, Timothy W Lineberry, Jennifer R Geske, Christi A Patten.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23963060     DOI: 10.1097/JCP.0b013e31829cc3cd

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN: 0271-0749            Impact factor:   3.153


× No keyword cloud information.
  8 in total

Review 1.  Nicotine receptor partial agonists for smoking cessation.

Authors:  Kate Cahill; Nicola Lindson-Hawley; Kyla H Thomas; Thomas R Fanshawe; Tim Lancaster
Journal:  Cochrane Database Syst Rev       Date:  2016-05-09

2.  "I Smoke Like This to Suppress These Issues That Are Flaws of My Character": Challenges and Facilitators of Cessation Among Smokers With Bipolar Disorder.

Authors:  Jaimee L Heffner; Noreen L Watson; Jennifer B McClure; Robert M Anthenelli; Sarah Hohl; Jonathan B Bricker
Journal:  J Dual Diagn       Date:  2018-01-19

3.  Acceptance and Commitment Therapy and nicotine patch for smokers with bipolar disorder: preliminary evaluation of in-person and telephone-delivered treatment.

Authors:  Jaimee L Heffner; Jennifer B McClure; Kristin E Mull; Robert M Anthenelli; Jonathan B Bricker
Journal:  Bipolar Disord       Date:  2015-04-25       Impact factor: 6.744

4.  Smokers with bipolar disorder, other affective disorders, and no mental health conditions: Comparison of baseline characteristics and success at quitting in a large 12-month behavioral intervention randomized trial.

Authors:  Jaimee L Heffner; Kristin E Mull; Noreen L Watson; Jennifer B McClure; Jonathan B Bricker
Journal:  Drug Alcohol Depend       Date:  2018-10-10       Impact factor: 4.492

5.  Pilot Randomized Controlled Trial of Web-Delivered Acceptance and Commitment Therapy Versus Smokefree.gov for Smokers With Bipolar Disorder.

Authors:  Jaimee L Heffner; Megan M Kelly; Jeanette Waxmonsky; Kristin Mattocks; Edit Serfozo; Jonathan B Bricker; Kristin E Mull; Noreen L Watson; Michael Ostacher
Journal:  Nicotine Tob Res       Date:  2020-08-24       Impact factor: 4.244

6.  Safety and efficacy of first-line smoking cessation pharmacotherapies in bipolar disorders: Subgroup analysis of a randomized clinical trial.

Authors:  Jaimee L Heffner; A Eden Evins; Cristina Russ; David Lawrence; Catherine R Ayers; Thomas McRae; Lisa St Aubin; Alok Krishen; Robert West; Robert M Anthenelli
Journal:  J Affect Disord       Date:  2019-06-03       Impact factor: 4.839

Review 7.  Smoking cessation and reduction in people with chronic mental illness.

Authors:  Jennifer W Tidey; Mollie E Miller
Journal:  BMJ       Date:  2015-09-21

8.  Differential SLC1A2 Promoter Methylation in Bipolar Disorder With or Without Addiction.

Authors:  Yun-Fang Jia; YuBin Choi; Jennifer R Ayers-Ringler; Joanna M Biernacka; Jennifer R Geske; Daniel R Lindberg; Susan L McElroy; Mark A Frye; Doo-Sup Choi; Marin Veldic
Journal:  Front Cell Neurosci       Date:  2017-07-21       Impact factor: 5.505

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.